WP
TMO icon

Waycross Partners’s Thermo Fisher Scientific TMO Stock Holding History

Waycross Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,014
Closed -$13.8M – 74
2024
Q2 		$13.8M Buy
25,014
+2,791
+13% +$1.6M 2.12% 18
2024
Q1 		$12.9M Buy
22,223
+1,784
+9% +$1M 2.22% 20
2023
Q4 		$10.8M Sell
20,439
-399
-2% -$193K 2.03% 21
2023
Q3 		$10.5M Buy
20,838
+1,063
+5% +$566K 2.33% 18
2023
Q2 		$10.3M Buy
+19,775
New +$10.7M 2.24% 21

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Waycross Partners's TMO Position: Q3 2024 in Review

Waycross Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 25,014 shares — an estimated $13.8M sold.

Waycross Partners first reported a position in TMO in Q2 2023 and held it in 5 quarters. The position peaked at $13.8M in Q2 2024. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Waycross Partners reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Waycross Partners sold 25,014 Thermo Fisher Scientific shares in Q3 2024, an estimated $13.8M.
  • Waycross Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 5 quarters.
  • Waycross Partners's Thermo Fisher Scientific position peaked at $13.8M in Q2 2024.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Waycross Partners's 13F filing for Q3 2024, filed 8 Nov 2024.